PL3737470T3 - Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści gpr40 - Google Patents

Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści gpr40

Info

Publication number
PL3737470T3
PL3737470T3 PL19701029.1T PL19701029T PL3737470T3 PL 3737470 T3 PL3737470 T3 PL 3737470T3 PL 19701029 T PL19701029 T PL 19701029T PL 3737470 T3 PL3737470 T3 PL 3737470T3
Authority
PL
Poland
Prior art keywords
phenyl
acid derivatives
hexynoic acid
gpr40 agonists
gpr40
Prior art date
Application number
PL19701029.1T
Other languages
English (en)
Inventor
Mateusz Mach
Radosław Dzida
Damian SMUGA
Filip STELMACH
Mikołaj Matłoka
Katarzyna Bazydło
Krzysztof DUBIEL
Maciej Wieczorek
Jerzy Pieczykolan
Original Assignee
Celon Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL424227A external-priority patent/PL233938B1/pl
Application filed by Celon Pharma S.A. filed Critical Celon Pharma S.A.
Publication of PL3737470T3 publication Critical patent/PL3737470T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19701029.1T 2018-01-08 2019-01-07 Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści gpr40 PL3737470T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL424227A PL233938B1 (pl) 2018-01-08 2018-01-08 Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści GPR40
PL42562518 2018-05-18
PCT/EP2019/050194 WO2019134984A1 (en) 2018-01-08 2019-01-07 3-phenyl-4-hexynoic acid derivatives as gpr40 agonists

Publications (1)

Publication Number Publication Date
PL3737470T3 true PL3737470T3 (pl) 2023-05-08

Family

ID=67144423

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19701029.1T PL3737470T3 (pl) 2018-01-08 2019-01-07 Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści gpr40

Country Status (14)

Country Link
US (1) US11964938B2 (pl)
EP (1) EP3737470B9 (pl)
JP (1) JP7289305B2 (pl)
KR (1) KR102705659B1 (pl)
CN (1) CN111757770B (pl)
AU (1) AU2019205093B2 (pl)
BR (1) BR112020013694A2 (pl)
DK (1) DK3737470T5 (pl)
ES (1) ES2939720T3 (pl)
FI (1) FI3737470T3 (pl)
MX (1) MX2020007283A (pl)
PL (1) PL3737470T3 (pl)
PT (1) PT3737470T (pl)
WO (1) WO2019134984A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
JP2023526625A (ja) 2020-05-19 2023-06-22 キャリーオペ,インク. Ampkアクチベーター
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
WO2025037230A1 (en) * 2023-08-11 2025-02-20 Life Code Limited Compositions, agents and preparations for promoting hair growth and/or mitigating hair loss
CN117343066A (zh) * 2023-09-05 2024-01-05 华南师范大学 喹唑啉酮生物碱Brevianamide M衍生物及制备方法与抗炎抗肿瘤应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003277576A1 (en) 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
EP1630152A4 (en) 2003-05-30 2009-09-23 Takeda Pharmaceutical CONDENSED CYCLIC COMPOUND
AU2004309271A1 (en) 2003-12-25 2005-07-14 Takeda Pharmaceutical Company Limited 3-(4-benzyloxyphenyl)propanoic acid derivatives
EA011010B1 (ru) 2004-02-27 2008-12-30 Эмджен, Инк. Соединения, модулирующие рецептор gpr40, фармацевтическая композиция, способ лечения заболеваний, чувствительных к модулированию рецептора gpr40 (варианты), способ модулирования функции gpr40 (варианты) и способ модулирования циркулирующей концентрации инсулина
EP1726580A4 (en) 2004-03-15 2008-02-13 Takeda Pharmaceutical AMINOPHNYLPROPANO ACID DERIVATIVE
WO2005118542A1 (en) 2004-05-28 2005-12-15 Eli Lilly And Company Glucagon receptor antagonists, preparation and therapeutic uses
WO2007033002A1 (en) * 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
ES2379661T3 (es) 2006-06-27 2012-04-30 Takeda Pharmaceutical Company Limited Compuestos cíclicos condensados
CA2662305C (en) 2006-09-07 2012-04-17 Amgen Inc. Heterocyclic gpr40 modulators
US7750048B2 (en) 2006-11-15 2010-07-06 Janssen Pharmaceutica Nv GPR40 agonists
US7572934B2 (en) 2007-04-16 2009-08-11 Amgen Inc. Substituted biphenyl GPR40 modulators
US20120172351A1 (en) 2009-06-09 2012-07-05 Nobuyuki Negoro Novel fused cyclic compound and use thereof
AR078522A1 (es) 2009-10-15 2011-11-16 Lilly Co Eli Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
MA34474B1 (fr) 2010-07-23 2013-08-01 Connexios Life Sciences Pvt Ltd Agonistes de gpr40
JP6054368B2 (ja) 2011-04-08 2016-12-27 カルダン セラピューティクス リミテッドCaldan Therapeutics Limited 代謝性疾患治療用o−フルオロ置換化合物またはその塩
TWI537262B (zh) 2011-08-17 2016-06-11 美國禮來大藥廠 供治療糖尿病使用之新穎1,2,3,4-四氫喹啉衍生物
JP6106179B2 (ja) 2012-02-24 2017-03-29 武田薬品工業株式会社 芳香環化合物
KR20140138243A (ko) 2012-02-28 2014-12-03 피라말 엔터프라이지즈 리미티드 G 단백질 연결 수용체 작용물질로서의 페닐알칸산 유도체
MX2016008910A (es) 2014-01-10 2016-10-04 Lilly Co Eli Compuestos de fenil-triazolo-piridina.
BR112017007720B1 (pt) * 2014-10-17 2023-01-17 Hyundai Pharm Co., Ltd. Composição contendo derivado de ácido 3-(4-(benzilóxi)fenil)hex-4-inoico e outro princípio ativo para prevenir ou tratar doenças metabólicas

Also Published As

Publication number Publication date
ES2939720T9 (es) 2024-06-04
EP3737470B1 (en) 2022-12-14
US20200399198A1 (en) 2020-12-24
KR20200108318A (ko) 2020-09-17
BR112020013694A2 (pt) 2020-12-01
ES2939720T3 (es) 2023-04-26
KR102705659B1 (ko) 2024-09-11
MX2020007283A (es) 2020-09-10
FI3737470T3 (fi) 2023-03-19
CN111757770B (zh) 2023-10-03
US11964938B2 (en) 2024-04-23
EP3737470A1 (en) 2020-11-18
CN111757770A (zh) 2020-10-09
DK3737470T3 (da) 2023-03-13
AU2019205093B2 (en) 2024-03-07
PT3737470T (pt) 2023-03-02
WO2019134984A1 (en) 2019-07-11
JP2021509909A (ja) 2021-04-08
CA3087712A1 (en) 2019-07-11
AU2019205093A1 (en) 2020-07-16
JP7289305B2 (ja) 2023-06-09
EP3737470B9 (en) 2024-03-13
DK3737470T5 (da) 2024-05-27

Similar Documents

Publication Publication Date Title
PT3737470T (pt) Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40
IL255111B (en) 3-Aryl-4-amino-[0,5,4] bicyclic hydroxamic acids as hdac inhibitors
EP3172185A4 (en) Substituted phenyl alkanoic acid compounds as gpr120 agonists and uses thereof
IL256265B (en) 3-tetrazolyl-benzene-2,1-disulfonamide derivatives as metallo-beta-lactamase inhibitors
LT3190113T (lt) Pirolopirimidino junginiai, naudotini kaip tlr7 agonistai
ZA201703112B (en) Substituted benzothiophenyl derivatives as gpr40 agonists for the treatment of type ii diabetes
EP3976576A4 (en) Gpr40 agonists
ZA201604527B (en) Compounds for use as gpr120 agonists
HUE052833T2 (hu) Eljárás 2,5-furándikarbonsav (FDCA) elõállítására
IL252882A0 (en) Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor agonists in the cell
ZA201905379B (en) 1-amino-1-cyclopropanecaboxylic acid formulations
EP3830103C0 (en) FLUORINATED BILE ACID DERIVATIVES
IL278933A (en) TLR7 agonists
SG11202100727VA (en) Boronic acid derivatives
SG11202003286YA (en) Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative
PL3672977T3 (pl) Pochodne kwasu boronowego
PL3679025T3 (pl) Podstawione imidazochinoliny jako agoniści tlr7
GB201805226D0 (en) Boronic Acid Derivatives For Sugar-sensing Hydrogels
EP3253745A4 (en) Compounds containing carbon-carbon linker as gpr120 agonists
EP3166405A4 (en) 3'-substituted-abscisic acid derivatives
EP3121188A4 (en) Crystalline 3',5'-cyclic diguanylic acid
SG11201803371YA (en) Novel citric acid derivative
EP4065155A4 (en) TLR7 AGONISTS
EP3279184A4 (en) Novel benzoic acid amide compound
HK40061615A (en) Erythropoietin analogs for veterinary use